drugset / Trial / NCT01593592
Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
Addition of L. reuteri to the standard triple therapy improves H. Pylori treatment outcomes.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Amoxicillin | Other / unclassified | 1000 mg | — |
| Background | Clarithromycin | Small molecule | 500 mg | — |
| Background | Omeprazole | Other / unclassified | 20 mg | — |